--- title: "REG - FIL Limited Dowlais Group PLC American Axle & Mfg. - Form 8.3 - AMERICAN AXLE & MFG HLDGS INC" description: "FIL Limited disclosed its position regarding American Axle & Manufacturing Holdings, Inc. in accordance with Rule 8.3 of the Takeover Code. As of September 29, 2025, FIL Limited holds 5,817,921 releva" type: "news" locale: "en" url: "https://longbridge.com/en/news/259540483.md" published_at: "2025-09-30T12:43:55.000Z" --- # REG - FIL Limited Dowlais Group PLC American Axle & Mfg. - Form 8.3 - AMERICAN AXLE & MFG HLDGS INC > FIL Limited disclosed its position regarding American Axle & Manufacturing Holdings, Inc. in accordance with Rule 8.3 of the Takeover Code. As of September 29, 2025, FIL Limited holds 5,817,921 relevant securities (4.90%) and cash-settled derivatives of 3,905,731 (3.29%), totaling 9,723,652 (8.19%). Recent transactions include purchases and sales of common shares at various prices. No indemnity or other dealing arrangements were reported. The disclosure was made on September 30, 2025, by Aaron Watson. RNS Number : 4585B FIL Limited 30 September 2025 FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the "Code") 1\. KEY INFORMATION (a) Full name of discloser: FMR LLC and/or one or more of its direct or indirect subsidiaries And FIL Limited and/or one or more of its direct and indirect subsidiaries (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor, and beneficiaries must be named. (c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree American Axle & Manufacturing Holdings, Inc (d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: (e) Date position held/dealing undertaken: For an opening position disclosure, state the latest practicable date prior to the disclosure 29-September-2025 (f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer? If it is a cash offer or possible cash offer, state "N/A" DOWLAIS GROUP PLC 2\. POSITIONS OF THE PERSON MAKING THE DISCLOSURE If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security. (a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any) Class of relevant security: USD 0.01 Common Interests Short positions Number % Number % (1) Relevant securities owned and/or controlled: 5,817,921 4.90% (2) Cash-settled derivatives: 3,905,731 3.29% (3) Stock-settled derivatives (including options) and agreements to purchase/sell: TOTAL: 9,723,652 8.19% All interests and all short positions should be disclosed Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions). (b) Rights to subscribe for new securities (including directors' and other employee options) - Class of relevant security in relation to which subscription right exists: - Details, including nature of the rights concerned and relevant percentages: 3\. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in. The currency of all prices and other monetary amounts should be stated. (a) Purchases and sales Class of relevant security Purchase/sale Number of securities Price per unit USD 0.01 Common Purchase 9 5.96 USD/Share USD 0.01 Common Purchase 1 5.97 USD/Share USD 0.01 Common Sale 1 6.24 USD/Share (b) Cash-settled derivative transactions Class of relevant security USD 0.01 Common Product description e.g. CFD Nature of dealing e.g. opening/closing a long/short position, increasing/reducing a long/short position Number of reference securities Price per unit (c) Stock-settled derivative transactions (including options) (i) Writing, selling, purchasing or varying - Class of relevant security - Product description e.g. call option - Writing, purchasing, selling, varying etc. - Number of securities to which option relates - Exercise price per unit - Typee.g. American, European etc. - Expiry date - Option money paid/ received per unit (ii) Exercise - Class of relevant security - Product descriptione.g. call option - Exercising/ exercised against - Number of securities - Exercise price per unit (d) Other dealings (including subscribing for new securities) - Class of relevant security - Nature of dealinge.g. subscription, conversion - Details - Price per unit (if applicable) 4\. OTHER INFORMATION (a) Indemnity and other dealing arrangements - Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none" - None. (b) Agreements, arrangements or understandings relating to options or derivatives - Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:(i) the voting rights of any relevant securities under any option; or(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:If there are no such agreements, arrangements or understandings, state "none" - None. (c) Attachments - Is a Supplemental Form 8 (Open Positions) attached? - No Date of disclosure: 30-September-2025 Contact name: Aaron Watson Telephone number: 00 353 1 223 1050 Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0) 20 7638 0129. The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk. This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com. RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy. END RETURSURVOUKOAR ### Related Stocks - [AXL.US - American Axle and Manufacturing](https://longbridge.com/en/quote/AXL.US.md) ## Related News & Research | Title | Description | URL | |-------|-------------|-----| | REG - 法國興業銀行 美國車橋製造 - 表格 8.3 - 美國車橋製造控股 | 法國興業銀行披露了其在美國車橋製造公司的持倉情況，顯示其擁有 478,780 股相關證券（佔 0.40%），並持有 809,133 股的空頭頭寸（佔 0.68%）。該披露包括最近購買和出售普通股的詳細信息，多個交易的價格範圍在 8.14 美 | [Link](https://longbridge.com/en/news/273529021.md) | | REG - FIL Limited Dowlais Group PLC 美國車橋製造 - 表格 8.3 - 美國車橋製造控股公司 | FIL Limited 根據收購守則第 8.3 條款披露了截至 2026 年 1 月 15 日對美國車橋製造（American Axle & Manufacturing Holdings, Inc.）的持倉情況。該披露包括相關證券的持有量總 | [Link](https://longbridge.com/en/news/272849022.md) | | 愛德華生命科學公司第四季度調整後的每股收益為 0.58 美元，而 IBES 的預期為 0.62 美元 | 2 月 10 日（路透社）- 愛德華生命科學第四季度銷售額為 15.696 億美元，超過 IBES 預估的 15.46 億美元。第四季度每股收益為 0.16 美元。第一季度銷售額展望為 15.50 億至 16.30 億美元，第一季度調整後每 | [Link](https://longbridge.com/en/news/275511936.md) | | 簡報 - 吉勞埃地產第四季度收入為 2.722 億美元，高於 IBES 預估的 2.714 億美元 | 2 月 9 日（路透社）- 吉勞埃地產第四季度每股收益為 0.1 美元。第四季度基金運營收益為 1.172 億美元。第四季度股息為 0.54 美元。第四季度淨收入為 1240 萬美元。全年每股基金運營收益預期為 3.25-3.45 美元 | [Link](https://longbridge.com/en/news/275362307.md) | | REG - Trium Capital LLP 美國車橋製造 - 表格 8.3 - 美國車橋製造 | Trium Capital LLP 根據收購守則第 8.3 條披露了其在美國車橋製造公司的持倉。截至 2026 年 1 月 7 日，Trium 持有 1,910,353 股相關證券（1.61%），並且有總計 45,209 股的空頭頭寸（0. | [Link](https://longbridge.com/en/news/271956353.md) | --- > **Disclaimer**: This article is for reference only and does not constitute any investment advice.